百奥赛图-B(02315)：A股发行注册获中证监批准
BiocytogenBiocytogen(HK:02315) 智通财经网·2025-10-16 12:01

Core Viewpoint - The China Securities Regulatory Commission has approved the A-share issuance registration application for Baiaosaitu-B (02315) on October 15, 2025 [1] Group 1 - The approval marks a significant step for the company in accessing the A-share market [1]